Portal Hypertension Recruiting Phase 4 Trials for Carvedilol (DB01136)

Also known as: Hypertension Portal / Hypertension, Portal / Portal hypertensions

IndicationStatusPhase
DBCOND0029015 (Portal Hypertension)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02945982Treatment of Moderate and Severe Cirrhotic Portal Hypertension Due to HBV With Fuzheng Huayu and EntecavirTreatment
NCT02907749Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in CirrhosisTreatment